Neogen (NASDAQ:NEOG) Issues Quarterly Earnings Results

Neogen (NASDAQ:NEOG) announced its quarterly earnings results on Tuesday. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.02), Briefing.com reports. Neogen had a net margin of 1.28% and a return on equity of 3.35%. The company had revenue of $228.80 million for the quarter, compared to analyst estimates of $230.01 million. During the same quarter last year, the business earned $0.12 EPS. The company’s revenue for the quarter was up 4.8% on a year-over-year basis. Neogen updated its FY 2024 guidance to EPS.

Neogen Trading Down 4.1 %

Shares of NEOG stock opened at $12.50 on Thursday. Neogen has a 12 month low of $12.18 and a 12 month high of $24.09. The company has a quick ratio of 2.63, a current ratio of 3.54 and a debt-to-equity ratio of 0.28. The business’s 50 day moving average is $15.92 and its two-hundred day moving average is $16.80. The company has a market cap of $2.71 billion, a PE ratio of 208.37 and a beta of 1.13.

Insider Buying and Selling at Neogen

In other Neogen news, CFO David H. Naemura acquired 12,500 shares of Neogen stock in a transaction dated Wednesday, April 10th. The stock was bought at an average cost of $12.51 per share, with a total value of $156,375.00. Following the completion of the transaction, the chief financial officer now owns 30,040 shares of the company’s stock, valued at $375,800.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Neogen news, CFO David H. Naemura acquired 12,500 shares of Neogen stock in a transaction dated Wednesday, April 10th. The stock was bought at an average cost of $12.51 per share, with a total value of $156,375.00. Following the completion of the transaction, the chief financial officer now owns 30,040 shares of the company’s stock, valued at $375,800.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO John Edward Adent acquired 23,000 shares of Neogen stock in a transaction dated Wednesday, April 10th. The stock was acquired at an average cost of $12.36 per share, with a total value of $284,280.00. Following the completion of the transaction, the chief executive officer now directly owns 152,389 shares of the company’s stock, valued at approximately $1,883,528.04. The disclosure for this purchase can be found here. Corporate insiders own 0.71% of the company’s stock.

Institutional Investors Weigh In On Neogen

Several hedge funds have recently modified their holdings of the business. BlackRock Inc. bought a new position in Neogen in the first quarter worth $451,277,000. Vanguard Group Inc. lifted its position in Neogen by 9.3% in the fourth quarter. Vanguard Group Inc. now owns 19,546,737 shares of the company’s stock worth $393,085,000 after purchasing an additional 1,663,125 shares during the period. Select Equity Group L.P. bought a new position in Neogen in the first quarter worth $147,849,000. State Street Corp raised its stake in Neogen by 2.9% during the second quarter. State Street Corp now owns 7,780,439 shares of the company’s stock worth $169,225,000 after acquiring an additional 216,035 shares in the last quarter. Finally, Geode Capital Management LLC acquired a new position in Neogen during the first quarter worth $84,319,000. 96.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, Piper Sandler increased their price target on Neogen from $17.50 to $19.00 and gave the company a “neutral” rating in a report on Thursday, January 18th.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.